COLUMBUS, Ohio, Oct. 2, 2024 /PRNewswire/ -- Ambetter from Buckeye Health Plan, a product offered by a Centene Corporation (NYSE: CNC) company which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace®, will offer a variety of affordable health insurance plans to Ohioans in 72 counties in plan year 2025. Open enrollment for the Health Insurance Marketplace for Ohio runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15 for coverage starting Jan. 1, 2025.
"More Ohioans can quickly and easily apply for the affordable healthcare marketplace coverage they need with expansion of Ambetter from Buckeye Health Plan," said Plan President and Chief Executive Officer, Steve Province. "Ambetter from Buckeye Health Plan members can get virtual 24/7 care via telehealth for nonemergency medical needs as well as the quality care and service Buckeye is known for."
Ambetter from Buckeye Health Plan offers its members access to quality care, convenient services and valuable rewards. The 2025 benefits and offerings include:
Below is the full list of counties in which Ambetter from Buckeye Health Plan will be offered in 2025:
Ohio residents interested in learning more about Ambetter from Buckeye Health Plan or enrolling in a health plan during the open enrollment period may visit ambetterhealth.com/en/oh/.
About Ambetter from Buckeye Health Plan & Ambetter Health
Ambetter from Buckeye Health Plan serves under-insured and uninsured populations through the federal Health Insurance Marketplace. Ambetter from Buckeye Health Plan is underwritten by Buckeye Community Health Plan, Inc., which is a Qualified Health Plan issuer in Ohio. Ambetter Health, offering the Ambetter Health Solutions product, is underwritten by Buckeye Health Plan Community Solutions, Inc. For more information visit ambetterhealth.com/en/oh/. This is a solicitation for insurance. For information on your right to receive an Ambetter from Buckeye Health Plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
Last Trade: | US$59.10 |
Daily Change: | 1.29 2.23 |
Daily Volume: | 4,074,504 |
Market Cap: | US$29.840B |
October 30, 2024 October 25, 2024 September 11, 2024 August 29, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB